At Aura Biosciences, we are developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed – an approach we call molecular surgery. By safely eliminating cancer locally, we can treat early and transform the lives of people with a wide range of cancers that are poorly managed today.
Our lead program in ocular melanoma is designed to remove cancer cells in the back of the eye as a first-line therapy potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Development of a first-in-class treatment option to selectively destroy cancer cells would create the possibility of a cure in this and other cancers where the disease can be detected early.
Research Associate, Process Development
Based in the Company’s North Cambridge office.
Aura Biosciences is seeking motivated individuals to join a team of scientists focused on the development of virus like particles (VLPs) for treatment of ocular melanoma. The RA/Sr. RA (depending on experience) will work with the Process Development group to execute operations for the production and purification of VLPs to support of preclinical and clinical programs.
- Execute experimental studies to support VLP process development including, screening, parameter optimization and process scale-up
- Support regular production of VLPs and drug substance (DS) to support development activities across multiple functions
- Document all experimental work and supporting information according to appropriate practices (e.g.,